These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 31346052)

  • 1. Lowering ceramides to overcome diabetes.
    Kusminski CM; Scherer PE
    Science; 2019 Jul; 365(6451):319-320. PubMed ID: 31346052
    [No Abstract]   [Full Text] [Related]  

  • 2. The ART of Lowering Ceramides.
    Summers SA
    Cell Metab; 2015 Aug; 22(2):195-6. PubMed ID: 26244926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compounds of the sphingomyelin-ceramide-glycosphingolipid pathways as secondary messenger molecules: new targets for novel therapies for fatty liver disease and insulin resistance.
    Ilan Y
    Am J Physiol Gastrointest Liver Physiol; 2016 Jun; 310(11):G1102-17. PubMed ID: 27173510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease.
    Wasilewska N; Bobrus-Chociej A; Harasim-Symbor E; Tarasów E; Wojtkowska M; Chabowski A; Lebensztejn DM
    Lipids Health Dis; 2018 Sep; 17(1):216. PubMed ID: 30208901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease.
    Luukkonen PK; Zhou Y; Sädevirta S; Leivonen M; Arola J; Orešič M; Hyötyläinen T; Yki-Järvinen H
    J Hepatol; 2016 May; 64(5):1167-1175. PubMed ID: 26780287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatty liver: cause or consequence.
    Hitman GA
    Diabet Med; 2012 Sep; 29(9):1097. PubMed ID: 22882641
    [No Abstract]   [Full Text] [Related]  

  • 7. Rheumatoid arthritis induced-fatty liver theory: one reason for global increase in prevalence of diabetes.
    Ahmed MH
    Med Hypotheses; 2006; 66(4):862-3. PubMed ID: 16403604
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of pioglitazone on plasma ceramides in adults with metabolic syndrome.
    Warshauer JT; Lopez X; Gordillo R; Hicks J; Holland WL; Anuwe E; Blankfard MB; Scherer PE; Lingvay I
    Diabetes Metab Res Rev; 2015 Oct; 31(7):734-44. PubMed ID: 25959529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceramides in insulin resistance and lipotoxicity.
    Summers SA
    Prog Lipid Res; 2006 Jan; 45(1):42-72. PubMed ID: 16445986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dorothy Hodgkin Lecture 2012: non-alcoholic fatty liver disease, insulin resistance and ectopic fat: a new problem in diabetes management.
    Byrne CD
    Diabet Med; 2012 Sep; 29(9):1098-107. PubMed ID: 22672330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of nonalcoholic fatty liver disease in the development of insulin resistance and diabetes.
    Grønbaek H; Thomsen KL; Rungby J; Schmitz O; Vilstrup H
    Expert Rev Gastroenterol Hepatol; 2008 Oct; 2(5):705-11. PubMed ID: 19072347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance.
    Asrih M; Jornayvaz FR
    J Endocrinol; 2013 Sep; 218(3):R25-36. PubMed ID: 23833274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-alcoholic fatty liver disease and microalbuminuria in non-diabetic patients: role of insulin resistance.
    Yilmaz Y; Alahdab YO; Ozdogan O; Dolar E
    Intern Med J; 2009 Oct; 39(10):709-10. PubMed ID: 19849765
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of Ceramide in Apoptosis and Development of Insulin Resistance.
    Kuzmenko DI; Klimentyeva TK
    Biochemistry (Mosc); 2016 Sep; 81(9):913-27. PubMed ID: 27682164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bezafibrate ameliorates diabetes via reduced steatosis and improved hepatic insulin sensitivity in diabetic TallyHo mice.
    Franko A; Neschen S; Rozman J; Rathkolb B; Aichler M; Feuchtinger A; Brachthäuser L; Neff F; Kovarova M; Wolf E; Fuchs H; Häring HU; Peter A; Hrabě de Angelis M
    Mol Metab; 2017 Mar; 6(3):256-266. PubMed ID: 28271032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of association of CPT1A polymorphisms or haplotypes on hepatic lipid content or insulin resistance in Japanese individuals with type 2 diabetes mellitus.
    Hirota Y; Ohara T; Zenibayashi M; Kuno S; Fukuyama K; Teranishi T; Kouyama K; Miyake K; Maeda E; Kasuga M
    Metabolism; 2007 May; 56(5):656-61. PubMed ID: 17445541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma sCD36 is associated with markers of atherosclerosis, insulin resistance and fatty liver in a nondiabetic healthy population.
    Handberg A; Højlund K; Gastaldelli A; Flyvbjerg A; Dekker JM; Petrie J; Piatti P; Beck-Nielsen H;
    J Intern Med; 2012 Mar; 271(3):294-304. PubMed ID: 21883535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the fatty liver index as an indicator of hepatic steatosis for predicting incident diabetes independently of insulin resistance in a Korean population.
    Jung CH; Lee WJ; Hwang JY; Yu JH; Shin MS; Lee MJ; Jang JE; Leem J; Park JY; Kim HK
    Diabet Med; 2013 Apr; 30(4):428-35. PubMed ID: 23278318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CerS2 haploinsufficiency inhibits β-oxidation and confers susceptibility to diet-induced steatohepatitis and insulin resistance.
    Raichur S; Wang ST; Chan PW; Li Y; Ching J; Chaurasia B; Dogra S; Öhman MK; Takeda K; Sugii S; Pewzner-Jung Y; Futerman AH; Summers SA
    Cell Metab; 2014 Oct; 20(4):687-95. PubMed ID: 25295789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sphingolipid Metabolism: New Insight into Ceramide-Induced Lipotoxicity in Muscle Cells.
    Bandet CL; Tan-Chen S; Bourron O; Le Stunff H; Hajduch E
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30678043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.